Skip to content

US-China Biomedical Technology, Inc.

company.status.inactive

CIK 1516079fmd_1BPTZ5826JDHEE8ZMZ73QQ313PServices · Services-Advertising AgenciesTemplate: Standard

Coverage: Mar 01, 2012 to May 31, 2019, 29 periods

Latest annual · FY2017

Millions
Total revenues
0
Operating income
(1)
Net income
(1)

Latest quarter · Q1 FY2020

Millions
Total revenues
0
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2014 to FY2017
n/m
Net income, 5 yearsFY2014 to FY2019
n/m

US-China Biomedical Technology, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
Operating income-$522,059-$515,52210-K 2019-06-12 · proof
Net income-$710,940-$482,16410-K 2019-06-12 · proof
Cash from operating activities-$544,670-$400,88910-K 2019-06-12 · proof
Total assets$77,487$80,626-3.9%10-K 2019-06-12 · proof
Total liabilities$76,078$352,433-78.4%10-K 2019-06-12 · proof
Cash and cash equivalents$36,542$56,407-35.2%10-K 2019-06-12 · proof
What was US-China Biomedical Technology, Inc.'s operating income in fiscal 2019?
US-China Biomedical Technology, Inc. reported operating income of -$522,059 for fiscal 2019 (the year ended Feb 28, 2019), against -$515,522 the year before. Source: the 10-K filed with the SEC on Jun 12, 2019. SEC
What was US-China Biomedical Technology, Inc.'s net income in fiscal 2019?
US-China Biomedical Technology, Inc. reported net income of -$710,940 for fiscal 2019 (the year ended Feb 28, 2019), against -$482,164 the year before. Source: the 10-K filed with the SEC on Jun 12, 2019. SEC
What was US-China Biomedical Technology, Inc.'s cash from operating activities in fiscal 2019?
US-China Biomedical Technology, Inc. reported cash from operating activities of -$544,670 for fiscal 2019 (the year ended Feb 28, 2019), against -$400,889 the year before. Source: the 10-K filed with the SEC on Jun 12, 2019. SEC
What are US-China Biomedical Technology, Inc.'s total assets?
As of Feb 28, 2019, US-China Biomedical Technology, Inc. reported total assets of $77,487, against $80,626 a year earlier (-3.9%). Source: the 10-K filed with the SEC on Jun 12, 2019. SEC
What are US-China Biomedical Technology, Inc.'s total liabilities?
As of Feb 28, 2019, US-China Biomedical Technology, Inc. reported total liabilities of $76,078, against $352,433 a year earlier (-78.4%). Source: the 10-K filed with the SEC on Jun 12, 2019. SEC
What are US-China Biomedical Technology, Inc.'s cash and cash equivalents?
As of Feb 28, 2019, US-China Biomedical Technology, Inc. reported cash and cash equivalents of $36,542, against $56,407 a year earlier (-35.2%). Source: the 10-K filed with the SEC on Jun 12, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1516079&period_type=annual&limit=5"

Information only, not investment advice.